New Paths for Global Innovation in Life Science Startups
Practical strategies for building global R&D partnerships that help biotech companies move drug programs toward clinical trials faster, conserve capital, and strengthen the evidence behind critical development decisions.
The conversation examined partnerships across the drug development pathway—from outsourced R&D and clinical trial site selection to collaborations with academia and large pharmaceutical companies.
- Cross-border R&D
- Clinical trials
- Partnerships
- Capital efficiency
- Faster drug development